INNOVATIVE CLINICAL TRIAL DESIGN AND DELIVERY: A PHASE 3 COVID-19 POST-EXPOSURE PROPHYLAXIS STUDY IN SKILLED NURSING AND ASSISTED LIVING FACILITIES (BLAZE-2)

Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2)

Abstract The a&d ej-123 efficient community spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the current pandemic of coronavirus disease-2019 (COVID-19), which in severe and critical cases results in progressive pulmonary infection, complicated by respiratory failure, with a high prevalence of acute respiratory

read more



Designing a P48-40 Chimeric Protein of Mycoplasma agalactiae and Highly Expression in E. coli, Applicable for Indirect ELISA

Abstract Mycoplasma agalactiae is an economically important pathogen and the main etiological agent of contagious agalactiae (CA) in small ruminants with a relatively high prevalence in sheep and a&d ej-123 goat, mainly characterized by mastitis, conjunctivitis and arthritis as predominant symptoms of a localized infection.Two genes encoding p48 an

read more

Managing the team communication of political leaders

Today, the problem of political leadership is, in fact, an actualized aspect which sets ground for identifying the changing political tendencies and realities in the contemporary world.In this given post-industrial context, to answer what the political leader and his team are, means to corroborate several vital issues in the field of political scie

read more